Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca-1+Lin- bone marrow progenitor cells:: Synergism with non-alloreactive (Host x Donor)F1 T cells

被引:50
作者
Bachar-Lustig, E [1 ]
Li, HW [1 ]
Gur, H [1 ]
Krauthgamer, R [1 ]
Marcus, H [1 ]
Reisner, Y [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
关键词
D O I
10.1182/blood.V94.9.3212.421k29_3212_3221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Induction of transplantation tolerance by means of bone marrow (BM) transplantation could become a reality if it was possible to achieve engraftment of hematopoietic stem cells under nonlethal preparatory cytoreduction of the recipient. To that end, BM facilitating cells, veto cells, or other tolerance-inducing cells, have been extensively studied. In the present study, we show that BM cells within the Sca-1(+)Lin(-) cell fraction, previously shown to be enriched for early hematopoietic progenitors, are capable of reducing specifically antidonor CTL-p frequency in vitro and in vivo, and of inducing split chimerism in sublethally 7-Gy-irradiated recipient mice across major histocompatibility complex barriers. The immune tolerance induced by the Sca-1(+)Lin(-) cells was also associated with specific tolerance toward donor-type skin grafts. The minimal number of cells required to overcome the host immunity remaining after 7 Gy total body irradiation is very large and, therefore, it may be very difficult to harvest sufficient cells for patients. This challenge was further addressed in our study by demonstrating that nonalloreactive (host x donor)F-1 T cells, previously shown to enhance T-cell-depleted BM allografts in lethally irradiated mice, synergize with Sca-1(+)Lin(-) cells in their capacity to overcome the major transplantation barrier presented by the sublethal mouse model. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:3212 / 3221
页数:10
相关论文
共 36 条
  • [1] SUCCESSFUL ENGRAFTMENT OF T-CELL-DEPLETED HAPLOIDENTICAL 3-LOCI INCOMPATIBLE TRANSPLANTS IN LEUKEMIA PATIENTS BY ADDITION OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS TO BONE-MARROW INOCULUM
    AVERSA, F
    TABILIO, A
    TERENZI, A
    VELARDI, A
    FALZETTI, F
    GIANNONI, C
    IACUCCI, R
    ZEI, T
    MARTELLI, MP
    GAMBELUNGHE, C
    ROSSETTI, M
    CAPUTO, P
    LATINI, P
    ARISTEI, C
    RAYMONDI, C
    REISNER, Y
    MARTELLI, MF
    [J]. BLOOD, 1994, 84 (11) : 3948 - 3955
  • [2] Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
    Aversa, F
    Tabilio, A
    Velardi, A
    Cunningham, I
    Terenzi, A
    Falzetti, F
    Ruggeri, L
    Barbabietola, G
    Aristei, C
    Latini, P
    Reisner, Y
    Martelli, MF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (17) : 1186 - 1193
  • [3] MEGADOSE OF T-CELL-DEPLETED BONE-MARROW OVERCOMES MHC BARRIERS IN SUBLETHALLY IRRADIATED MICE
    BACHARLUSTIG, E
    RACHAMIM, N
    LI, HW
    LAN, FS
    REISNER, Y
    [J]. NATURE MEDICINE, 1995, 1 (12) : 1268 - 1273
  • [4] A MODIFIED TECHNIQUE FOR EXPERIMENTAL SKIN-GRAFTING
    BAHARAV, E
    LIDER, O
    MARGALIT, M
    COHEN, IR
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 90 (01) : 143 - 144
  • [5] BLOCKADE OF THE CD28 COSTIMULATORY PATHWAY - A MEANS TO INDUCE TOLERANCE
    BOUSSIOTIS, VA
    GRIBBEN, JG
    FREEMAN, GJ
    NADLER, LM
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (05) : 797 - 807
  • [6] CAVAZZANACALVO M, 1994, BLOOD, V83, P288
  • [7] MONOCLONAL-ANTIBODIES TO PROMOTE MARROW ENGRAFTMENT AND TISSUE GRAFT TOLERANCE
    COBBOLD, SP
    MARTIN, G
    QIN, S
    WALDMANN, H
    [J]. NATURE, 1986, 323 (6084) : 164 - 166
  • [8] The use of tolerance for transplantation across xenogeneic barriers
    Greenstein, JL
    Sachs, DH
    [J]. NATURE BIOTECHNOLOGY, 1997, 15 (03) : 235 - 238
  • [9] Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: A method to ameliorate graft-versus-host disease and extend the donor pool
    Gribben, JG
    Guinan, EC
    Boussiotis, VA
    Ke, XY
    Linsley, L
    Sieff, C
    Gray, GS
    Freeman, GJ
    Nadler, LM
    [J]. BLOOD, 1996, 87 (11) : 4887 - 4893
  • [10] KAUFMAN CL, 1994, BLOOD, V84, P2436